5439042025-10-012025-12-315439042025-04-012025-12-315439042025-10-012025-12-31in-capmkt:OtherExpenses1Member5439042025-04-012025-12-31in-capmkt:OtherExpenses1Member5439042025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15439042025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25439042025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35439042025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45439042025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15439042025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25439042025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35439042025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45439042025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15439042025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15439042025-10-012025-12-31AuditorDomain15439042025-10-012025-12-31AuditorDomain2iso4217:INRiso4217:INRxbrli:shares543904MANKINDNOTLISTEDINE634S01028MANKIND PHARMA LIMITEDMain BoardEquity2025-04-012026-03-312026-02-032026-01-09INRCroresQuarterlyThird quarterSingle segmentPharmaceuticals2026-02-0315:00:002026-02-0315:45:00Declaration of unmodified opinion2025-10-012025-12-31UnauditedConsolidated3567200000072750000036399500000553040000041167000001328000008237100000157200000022260000008460700000302757000006123800000-106590000050579000001538800000-5876000009512000000410670000000032100000413880000059500000419830000040875000005130000041477000005060000041280000019.99.89009.99.89Due to limitation of characters in xbrl utility, we are facing constraints to disclose all notes to accounts. Kindly refer PDF version of financials results uploaded on the Stock Exchanges website: www.bseindia.com and www.nseindia.com and also on the Company’s website: www.mankindpharma.com.2025-04-012025-12-31UnauditedConsolidated1083471000002445000000110792100000173308000001229610000013106000002432300000049753000006631000000262113000009307810000017714000000-1065900000166481000003900100000-95180000029483000000136998000000008700000013786800000281000000140678000001358580000020100000013866300000201500000412800000132.9132.870032.9132.87Other expenses8460700000Other expenses26211300000Remeasurement gain / (loss) of the defined benefit plan-38900000Share of other comprehensive income/(loss) of associates and joint ventures0Change in the fair value of equity investments at FVTOCI61800000Impairment on investment measured at FVTOCI022900000Remeasurement gain / (loss) of the defined benefit plan-28600000Share of other comprehensive income/(loss) of associates and joint ventures0Change in the fair value of equity investments at FVTOCI254800000Impairment on investment measured at FVTOCI-62000000164200000-450000027100000Exchange differences in translating the financial statements of foreign operations3210000032100000Exchange differences in translating the financial statements of foreign operations1439000001439000000059500000281000000UnauditedtrueS.R. Batliboi & Co. LLPtrue2027-07-31Bhagi Bhardwaj Gaur & Cotrue2028-05-31